Article
Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.
Biochemical and biophysical research communications - 8 Oct 2010
Flück Christa E, Mullis Primus E, Pandey Amit V
Abstract excerpt
Cytochrome P450 3A4 (CYP3A4), the major P450 present in human liver metabolizes approximately half the drugs in clinical use and requires electrons supplied from NADPH through NADPH-P450 reductase (POR, CPR). Mutations in human POR cause a rare form of congenital adrenal hyperplasia from diminished activities of steroid metabolizing P450s. In this study we examined the effect of mutations in POR on CYP3A4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
